Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients
โ Scribed by T. Berghmans; M. Paesmans; J. Lafitte; C. Mascaux; A. Meert; C. Jacquy; A. Burniat; E. Steels; F. Vallot; J. Sculier
- Publisher
- Springer-Verlag
- Year
- 2002
- Tongue
- English
- Weight
- 56 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0941-4355
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract We previously established 2 lung cancer cell lines, OKaโCโ1 and MIโ4, which constitutively produce an abundant dose of granulocyteโcolony stimulating factor (GโCSF) and granulocyte macrophageโcolony stimulating factor (GMโCSF). Many other cases with GโCSF or GMโCSF producing tumors have
## Abstract Cycling intensive chemotherapy currently used to treat pediatric solid tumors induces severe neutropenia. Prolonged neutropenia is a major risk factor for septic death which occurs in up to 5% of febrile or septic neutropenic episodes. We treated 18 neutropenic pediatric cancer patients